DEVICE CATEGORY · SJQ
Immunoassay For Host Biomarkers To Predict Risk Of 28-Day All-Cause Mortality In Patients With Sepsis And Septic Shock.
An immunoassay used to detect host biomarkers as an aid to assess the risk of 28-day all-cause mortality in patients with sepsis and septic shock.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| B·R·A·H·M·S GmbH (part of Thermo Fisher Scientific) | 510(k) clearance | Oct 23, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
